The Impact of Oral Glutathione on Oxidative Damage and Glycated Hemoglobin (HbA1c) Levels in Type 2 Diabetes Patients
NCT ID: NCT06313164
Last Updated: 2025-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
217 participants
INTERVENTIONAL
2023-06-20
2024-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypothesis: The anticipated outcome is a significant increase in GSH levels and a decrease in markers of oxidative damage among participants receiving L-glutathione compared to those in the placebo group, potentially indicating improved antioxidant defenses and some effects on glycemic regulation in T2D patients. This trial aims to fill gaps in current research regarding the role of L-glutathione supplementation in managing oxidative stress and metabolic control in diabetes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Lycopene and Isoflavones on Glucose Metabolism
NCT01377961
Glutathione-rich Foods for Type 2 Diabetes
NCT04386187
The Production of Reactive Oxygen Species in Response to Glutathione Supplementation and Acute Exercise
NCT02948673
The Effect of Pyridoxamine Supplementation on Microvascular Function in Type 2 Diabetes
NCT06376240
Effects of 5-Aminolevulinic Acid on Glucose Metabolism
NCT01610778
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
enhanced L-gluthathione group
enhanced glutathione
L-glutathione (in combination with tannin, low molecular weight chitosan and polyethylene glycol)
placebo group
placebo comparator
placebo group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
enhanced glutathione
L-glutathione (in combination with tannin, low molecular weight chitosan and polyethylene glycol)
placebo comparator
placebo group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* heavy smoking: Individuals consuming more than 20 cigarettes per day;
* excessive alcohol consumption: Participants who consume alcohol in excess of established limits, defined as more than 14 standart doses for men and 7 for woman;
* active clinical infections
* recent cardiovascular events: Individuals who suffered from cardiovascular event in the last 6 months;
* subjects receiving antioxidant drugs or dietary supplements;
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Center of New Medical Technologies
OTHER
S.LAB (SOLOWAYS)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center of New Medical Technologies
Novosibirsk, Novosibisk Region, Russia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SW009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.